Phase I Clinical Trial of TQB3915 Tablets in Subjects With Advanced Malignant Solid Tumors

NCT05416359 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignant Tumor

Interventions

DRUG: TQB3915 tablets

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.